Basic Information
| RNALocate ID: | RLID:11003115 |
| RNA Symbol: | hsa-miR-502-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-502-5p |
| RNA ID: | miRBase:MIMAT0002873 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | Primary dendritic cells|T cell line (J77) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002356 | Cytoplasm | GC cell lines (MKN-28|MKN-45) | 30953514 |
| RLID:01002357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003116 | Exosome | Brain tissue | 23382797 |
| RLID-D:11001300 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11003979 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-502-5p | Oral squamous cell carcinoma | MNDR-E-MI-55658 |
| MNDR | hsa-miR-502-5p | Large cell neuroendocrine cancer | MNDR-E-MI-55659 |
| MNDR | hsa-miR-502-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-55660 |
| MNDR | hsa-miR-502-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-55661 |
| MNDR | hsa-miR-502-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-55662 |
| MNDR | hsa-miR-502-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-55663 |
| MNDR | hsa-miR-502-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-55664 |
| MNDR | hsa-miR-502-5p | Her2-receptor positive breast cancer | MNDR-E-MI-55665 |
| MNDR | hsa-miR-502-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-55666 |
| MNDR | hsa-miR-502-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-55667 |
| MNDR | hsa-miR-502-5p | Prostate cancer | MNDR-E-MI-55668 |
| MNDR | hsa-miR-502-5p | Gastric cancer | MNDR-E-MI-55669 |
| MNDR | hsa-miR-502-5p | Alzheimer disease | MNDR-E-MI-55670 |
| MNDR | hsa-miR-502-5p | Dysautonomia familial | MNDR-E-MI-55671 |
| MNDR | hsa-miR-502-5p | Leukemia | MNDR-E-MI-55672 |
| MNDR | hsa-miR-502-5p | Lung cancer | MNDR-E-MI-55673 |
| MNDR | hsa-miR-502-5p | Parkinson disease | MNDR-E-MI-55674 |
| MNDR | hsa-miR-502-5p | Breast cancer | MNDR-E-MI-55675 |
| MNDR | hsa-miR-502-5p | Pancreatic cancer | MNDR-E-MI-55676 |
| MNDR | hsa-miR-502-5p | Melanoma | MNDR-E-MI-55677 |
| MNDR | hsa-miR-502-5p | Rectum adenocarcinoma | MNDR-E-MI-55678 |
| MNDR | hsa-miR-502-5p | Nephroblastoma | MNDR-E-MI-55679 |
| MNDR | hsa-miR-502-5p | Colon cancer | MNDR-E-MI-55680 |
| MNDR | hsa-miR-502-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-55681 |
| MNDR | hsa-miR-502-5p | Familial ovarian cancer | MNDR-E-MI-55682 |
| MNDR | hsa-miR-502-5p | Prostate adenocarcinoma | MNDR-E-MI-55683 |
| MNDR | hsa-miR-502-5p | Glioma | MNDR-E-MI-55684 |
| MNDR | hsa-miR-502-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-55685 |
| MNDR | hsa-miR-502-5p | Epilepsy temporal lobe | MNDR-E-MI-55686 |
| MNDR | hsa-miR-502-5p | Osteosarcoma | MNDR-E-MI-55687 |
| MNDR | hsa-miR-502-5p | Gastric adenocarcinoma | MNDR-E-MI-55688 |
| MNDR | hsa-miR-502-5p | Cervical squamous cell carcinoma | MNDR-E-MI-55689 |
| MNDR | hsa-miR-502-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-55690 |
| MNDR | hsa-miR-502-5p | Lung squamous cell carcinoma | MNDR-E-MI-55691 |
| MNDR | hsa-miR-502-5p | Lung adenocarcinoma | MNDR-E-MI-55692 |
| MNDR | hsa-miR-502-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-55693 |
| MNDR | hsa-miR-502-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-55694 |
| MNDR | hsa-miR-502-5p | Clear cell renal cell carcinoma | MNDR-E-MI-55695 |
| MNDR | hsa-miR-502-5p | Oncocytoma | MNDR-E-MI-55696 |
| MNDR | hsa-miR-502-5p | Lung small cell carcinoma | MNDR-E-MI-55697 |
| MNDR | hsa-miR-502-5p | T acute lymphoblastic leukemia | MNDR-E-MI-55698 |
| MNDR | hsa-miR-502-5p | Acute t cell leukemia | MNDR-E-MI-55699 |
| MNDR | hsa-miR-502-5p | Hepatocellular carcinoma | MNDR-E-MI-55700 |
| MNDR | hsa-miR-502-5p | Familiar ovarian carcinoma | MNDR-E-MI-55701 |
| MNDR | hsa-miR-502-5p | B-cell lymphoma | MNDR-E-MI-55702 |
| MNDR | hsa-miR-502-5p | Retinoblastoma | MNDR-E-MI-55703 |
| MNDR | hsa-miR-502-5p | Barrett's adenocarcinoma | MNDR-E-MI-55704 |
| MNDR | hsa-miR-502-5p | Colorectal cancer | MNDR-E-MI-55705 |
| MNDR | hsa-miR-502-5p | Ependymoma | MNDR-E-MI-55706 |
| MNDR | hsa-miR-502-5p | Stroke lacunar | MNDR-E-MI-55707 |
| MNDR | hsa-miR-502-5p | Barrett's carcinogenesis | MNDR-E-MI-55708 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | IFI27 | Homo sapiens | RR00740326 |
TOP